Nitric oxide for the treatment of preterm infants with respiratory distress syndrome

Introduction: Inhaled Nitric oxide (iNO) has been proposed as effective treatment for improving oxygenation in preterm infants with respiratory distress syndrome (RDS), and for preventing the development of bronchopulmonary dysplasia (BPD).